PAVmed (PAVM) Equity Average (2016 - 2025)

PAVmed has reported Equity Average for 10 years, with the latest figure at $27.4 million in Q4 2025.

• For the quarter ending Q4 2025, Equity Average rose 722.88% year-over-year to $27.4 million; the trailing twelve-month figure through Dec 2025 stood at $27.4 million (up 722.88% YoY), and the FY2025 full-year result was $9.9 million, up 174.7% from the prior year.
• Equity Average for Q4 2025 stood at $27.4 million, down from $30.3 million in the prior quarter.
• The five-year high for Equity Average was $72.1 million in Q1 2022, with the low at -$22.3 million in Q1 2024.
• Average Equity Average over 5 years is $19.9 million, with a median of $21.8 million recorded in 2021.
• Year-over-year, Equity Average surged 852.61% in 2021 and tumbled 493.19% in 2024.
• Tracing PAVM's Equity Average over 5 years: stood at $57.3 million in 2021, then plunged by 65.56% to $19.7 million in 2022, then slumped by 200.9% to -$19.9 million in 2023, then jumped by 116.72% to $3.3 million in 2024, then jumped by 722.88% to $27.4 million in 2025.
• The last three Equity Average figures came in at $27.4 million (Q4 2025), $30.3 million (Q3 2025), and $33.5 million (Q2 2025), per Business Quant data.

Peer Comparison